Performance across different versions of an artificial intelligence model for screen-reading of mammograms
Objectives: Studies have reported promising results regarding artificial intelligence (AI) as a tool for improved mammographic screening interpretive performance. We analyzed AI malignancy risk scores from two versions of the same commercial AI model. Materials and methods: This retrospective cohort study used data from 117,709 screening examinations performed in BreastScreen Norway 2009–2018. The
